Welcome! Accelerate Your Discovery

Be a part of a committed society that is shaping the future of knowledge Search

The Impact of HIV Decriminalization Policies on Public Health Outcomes: A Systematic Review

Article Number: SIS826931AI190125
19th January, 2025
Author(s):
Isaac Buabeng Bempong
Abstract:

HIV decriminalization policies have emerged as a pivotal strategy in addressing the global HIV epidemic. This systematic review examines the impact of these policies on public health outcomes, focusing on HIV transmission rates, access to healthcare, stigma reduction, and broader systemic benefits. Drawing on studies conducted between 2019 and 2024, the review synthesizes findings from diverse geographical and social contexts, highlighting the transformative potential of decriminalization in mitigating the structural barriers associated with criminalization. The results indicate that decriminalization policies are associated with significant reductions in HIV transmission rates, with programs such as needle exchange initiatives and harm reduction services demonstrating measurable efficacy. Decriminalization also facilitates improved access to healthcare services, particularly for marginalized populations such as people living with HIV, injecting drug users, and sex workers. Additionally, these policies contribute to substantial reductions in stigma, fostering societal acceptance and encouraging engagement with healthcare systems. Despite these positive outcomes, the review identifies persistent challenges, including gaps in data from low- and middle-income countries and the need for comprehensive strategies that address broader social determinants of health. The findings reinforce the importance of integrating decriminalization policies with robust public health frameworks and community education campaigns to maximize their impact. This review contributes to the existing body of knowledge by providing actionable insights for policymakers and health practitioners, emphasizing the necessity of decriminalization as a cornerstone of equitable and effective global HIV prevention and treatment strategies. Further research is recommended to explore the long-term impacts and scalability of these policies in diverse contexts.

Share article

Recommended Articles

The Dilemma of Graduates’ Skills Acquisition in ...
Sidi Istifanus Abimi...
Free Trade Zones, Graduates’ Skills Acquisition, Employment Generation, Tertiary Institutions

Unemployment among graduates of tertiary institutions in Nigeria has remained a persistent socio-ec... 4 months ago

Secondary Syphilis with Osteitis
Blanca Santos Latasa...
secondary syphilis, osteitis, Treponema pallidum, HIV coinfection, lytic bone lesion, subgaleal nodules, technetium-99m bone scan, RPR titer, TPPA, penicillin G benzathine, CT imaging, macular rash, bone biopsy

A 32-year-old man with well-controlled HIV presented with a 1-month history of painful forehead nodu... 5 months ago

Safety of Kidney Transplantation from Donors with ...
Christine M. Durand,...
kidney transplantation, HIV-positive donor, HIV-positive recipient, HOPE Act, organ equity, graft survival, HIV superinfection, antiretroviral therapy, opportunistic infection, immunosuppression, rejection, donor-derived infection

This multicenter, observational, noninferiority study evaluated the safety of kidney transplantation... 5 months ago

Safety and Efficacy of Immunization with a Late-Li...
Olivia A.C. Lamers, ...
malaria vaccine, Plasmodium falciparum, genetically attenuated parasite, GA2, GA1, liver-stage arrest, controlled human malaria infection, CHMI, mosquito bite immunization, PfCSP, PfAMA1, PfMSP1, CD4+ T cells

   This double-blind, controlled clinical trial evaluated the safety and efficacy of immun... 5 months ago

RENOIR Trial — RSVpreF Vaccine Efficacy over Two...
Edward E. Walsh, Gon...
RSVpreF vaccine, RENOIR trial, respiratory syncytial virus, RSV A, RSV B, older adults, vaccine durability, lower respiratory tract illness, acute respiratory illness, bivalent vaccine, post hoc analysis, seasonal surveillance

his letter reports extended efficacy data from the phase 3 RENOIR trial evaluating the bivalent RSVp... 5 months ago

Reducing the Cost of Saving Children’s Lives
Elizabeth Miller
pneumococcal conjugate vaccine, PCV10, PCV13, fractional dosing, reduced-dose schedule, vaccine immunogenicity, herd immunity, vaccine-serotype carriage, Gavi, cost-effectiveness, Kenya, Vietnam, Niger, Gambia

This editorial discusses two cost-saving strategies for pneumococcal conjugate vaccine (PCV) program... 5 months ago

Primary Cutaneous Herpes Simplex Virus Infection o...
Alejandro Claudio-Ol...
herpes simplex virus type 1, HSV-1, primary cutaneous infection, pediatric dermatology, impetigo mimic, vesicular lesion, satellite vesicles, cervical lymphadenopathy, herpes labialis, oral acyclovir, PCR diagnosis

A 9-year-old girl presented with a 7-day history of a cheek lesion and 4 days of fever. Initially tr... 5 months ago

Preventing and Controlling Global Antimicrobial Re...
Don Goldmann, Sowmya...
antimicrobial resistance, AMR, SPIDAAR, whole-system approach, surveillance systems, microbiology laboratories, leapfrog innovations, frugal diagnostics, failure mode analysis, One Health, Uganda Ministry of Health

   This Perspective advocates for a whole-system approach to combating antimicrobial resis... 5 months ago

Preparing for the Next Pandemic — Expanding and ...
Sam Halabi, George L...
pandemic preparedness, global regulatory capacity, WHO-listed authorities, vaccine access, diagnostics, therapeutics, emergency use listing, prequalification, regulatory bottlenecks, maturity level, decentralized approval

   This Perspective argues for expanded and coordinated global regulatory capacity to ensu... 5 months ago

Levofloxacin Preventive Treatment in Children Expo...
Anneke C. Hesseling,...
levofloxacin, MDR tuberculosis, TB-CHAMP trial, pediatric TB prevention, household exposure, South Africa, fluoroquinolone, randomized controlled trial, IGRA, HIV, adverse events, tendonitis, preventive therapy

This double-blind, cluster-randomized, placebo-controlled trial (TB-CHAMP) evaluated the efficacy an... 5 months ago

Postacute Sequelae of SARS-CoV-2 Infection in the ...
Yan Xie, Taeyoung Ch...
long Covid, postacute sequelae, SARS-CoV-2, Covid-19, PASC, pandemic era comparison, pre-delta, delta, omicron, vaccination, Veterans Affairs, cohort study, disability-adjusted life-years, DALY, viral evolution

   This retrospective cohort study used U.S. Department of Veterans Affairs health records... 5 months ago

Gender-Affirming Surgical Care in Carceral Setting...
Matthew Murphy, Carl...
Gender-affirming surgery, transgender health, carceral settings, prison healthcare, WPATH standards, Eighth Amendment, PREA, Medicaid, health equity

Abstract:Transgender and gender nonconforming (trans) individuals face disproportionate incarceratio... 5 months ago

Oral Nirmatrelvir–Ritonavir as Postexposure Prop...
Jennifer Hammond, Ca...
nirmatrelvir, ritonavir, Paxlovid, Covid-19, SARS-CoV-2, postexposure prophylaxis, household transmission, randomized controlled trial, omicron variant, dysgeusia, viral load, EPIC-HR trial, seroprevalence, antiviral safety

This phase 2–3 double-blind, placebo-controlled trial evaluated the efficacy and safety of oral ni... 5 months ago

Fracture Prevention with Infrequent Zoledronate in...
Mark J. Bolland, Zay...
Zoledronate, fracture prevention, postmenopausal women, osteopenia, bone mineral density, vertebral fracture, bisphosphonates, osteoporosis, clinical trial

This 10 year, double blind, randomized, placebo controlled trial investigated the efficacy of infreq... 5 months ago

Oral Hairy Leukoplakia
Meropi Karakioulaki,...
oral hairy leukoplakia, Epstein–Barr virus, EBV reactivation, immunocompromised host, kidney transplantation, tacrolimus, mycophenolate mofetil, tongue lesions, parakeratosis, hyperkeratosis, vacuolated keratinocytes

A 38-year-old man with a history of kidney transplantation presented with a 2-week history of burnin... 5 months ago

Estimates of Cardiovascular Risks and Benefits —...
George A. Mensah, M....
Cardiovascular disease, risk factors, hypertension, hyperlipidemia, obesity, diabetes, smoking, prevention, lifetime risk, global health

Cardiovascular diseases remain the leading cause of global mortality, with over 19.8 million deaths ... 5 months ago

Nirsevimab and Hospitalization for RSV Bronchiolit...
Zein Assad, Anne-Sop...
nirsevimab, RSV, bronchiolitis, hospitalization, monoclonal antibody, pediatric infectious disease, passive immunization, palivizumab, ventilatory support, PICU admission, real-world effectiveness, case-control study, French

This prospective, multicenter, matched case-control study assessed the real-world effectiveness of n... 5 months ago

Enteral Nutrition in Hospitalized Adults
Leah Gramlich, M.D.,...
Enteral nutrition, malnutrition, medical nutrition therapy, intensive care unit, hospitalized adults, inflammation, feeding protocols, critical illness, recovery, patient outcomes

Enteral nutrition is a critical intervention for preventing and treating disease related malnutritio... 5 months ago

Levofloxacin for the Prevention of Multidrug-Resis...
Greg J. Fox, Nguyen ...
levofloxacin, multidrug-resistant tuberculosis, MDR-TB, rifampicin-resistant TB, Vietnam, household contacts, latent TB infection, preventive therapy, fluoroquinolone, randomized controlled trial, adverse events, drug resistance

This randomized, double-blind, placebo-controlled trial evaluated the efficacy and safety of a 6-mon... 5 months ago